ACETAZOLAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Acetazolamide patents expire, and what generic alternatives are available?
Acetazolamide is a drug marketed by Accord Hlthcare, Alembic, Cadila, Heritage Pharma, Indicus Pharma, Micro Labs Ltd India, Nostrum Labs Inc, Novast Labs, Rising, Ajanta Pharma Ltd, Alra, Appco, Ascot, Breckenridge, Chartwell Molecular, Epic Pharma Llc, Hibrow Hlthcare, Mankind Pharma, Ne Rx Pharma, Novitium Pharma, Rubicon, Strides Pharma, Sun Pharm Industries, Taro, Torrent, Vangard, Watson Labs, Zydus Lifesciences, Avet Lifesciences, Endo Operations, Hikma, Hospira, Mylan Asi, Xgen Pharms, and Zydus Pharms. and is included in thirty-seven NDAs.
The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetazolamide
A generic version of ACETAZOLAMIDE was approved as acetazolamide sodium by HIKMA on February 28th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACETAZOLAMIDE?
- What are the global sales for ACETAZOLAMIDE?
- What is Average Wholesale Price for ACETAZOLAMIDE?
Summary for ACETAZOLAMIDE
| US Patents: | 0 |
| Applicants: | 35 |
| NDAs: | 37 |
| Finished Product Suppliers / Packagers: | 33 |
| Raw Ingredient (Bulk) Api Vendors: | 125 |
| Clinical Trials: | 147 |
| Patent Applications: | 4,801 |
| Drug Prices: | Drug price information for ACETAZOLAMIDE |
| DailyMed Link: | ACETAZOLAMIDE at DailyMed |
Recent Clinical Trials for ACETAZOLAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Incannex Healthcare Ltd | Phase 2/Phase 3 |
| Johannes Grand | Phase 4 |
| University of Arizona | Early Phase 1 |
Pharmacology for ACETAZOLAMIDE
| Drug Class | Carbonic Anhydrase Inhibitor |
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
Medical Subject Heading (MeSH) Categories for ACETAZOLAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for ACETAZOLAMIDE
US Patents and Regulatory Information for ACETAZOLAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torrent | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 213706-002 | Jan 26, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rubicon | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 215101-001 | Aug 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 040108-001 | Oct 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211069-002 | Apr 4, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Asi | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 200880-001 | May 9, 2012 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ne Rx Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197-001 | May 9, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
